Proteome Sciences News Today

Proteome Sciences plc (LON:PRM – Get Free Report) crossed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of GBX 3.53 ($0.05) and traded as high as GBX 4.25 ($0.05). Proteome Sciences shares last traded at GBX 4.16 ($0.05), with a volume of 1,190,000 shares. Proteome Sciences […]

Shares of Proteome Sciences plc (LON:PRM – Get Free Report) were down 18.1% on Monday . The stock traded as low as GBX 3.32 ($0.04) and last traded at GBX 3.48 ($0.04). Approximately 139,794 shares traded hands during mid-day trading, a decline of 22% from the average daily volume of 178,180 shares. The stock had […]

The following stocks are the leading risers and fallers on AIM in London on Thursday. ---------- AIM - WINNERS ---------- Proteome Sciences PLC, up 14% at 3.99 pence, 12-month range 2.65p-8.79p. The...

Proteome Sciences PLC - London-based protein-focused drug development services provider - Proteome tells annual general meeting on Thursday it is confident and well positioned to see the business...

Proteome Sciences ( LON:PRM ) Full Year 2023 Results Key Financial Results Revenue: UK£5.03m (down 35% from FY 2022...

Proteome Sciences (GB:PRM) has released an update. Proteome Sciences has announced a significant contract win worth over £500,000 with a US biophar...

Stock prices in London opened higher on Friday, as investors shook off nerves ahead of US inflation data this afternoon. The FTSE 100 index opened up 42.14 points, 0.5%, at 8,121.00. The FTSE 250 was...

The following stocks are the leading risers and fallers on AIM in London on Friday. ---------- AIM - WINNERS ---------- Proteome Sciences PLC, up 31% at 4.59 pence, 12-month range 2.65p-8.79p. The...

Proteome Sciences PLC on Friday said it won a contract from an unnamed US biopharmaceutical company to use Proteomes mass spectrometry services. The protein-focused drug development services...

/PRNewswire/ -- Biomarkers Market in terms of revenue was estimated to be worth $57.7 billion in 2024 and is poised to reach $93.8 billion by 2029, growing at...